| Name
|
VIR-165
|
| Other Name
|
|
| Sequence (Single letter abbreviations)
|
LEAIPCSIPPCFAFNKPFVF
|
| Sequence（Three letter abbreviations）
|
{Leu}{Glu}{Ala}{Ile}{Pro}{Cys}{Ser}{Ile}{Pro}{Pro}{Cys}{Phe}{Ala}{Phe}{Asn}{Lys}{Pro}{Phe}{Val}{Phe}
|
| C-port
|
NH2
|
| Basic description
|
VIR-165 is a modified form of virus inhibitory peptide (VIRIP), which corresponds to residues 353 to 372 of C-proximal region of human alpha1-antitrypsin, the more abundant circulating serine protease inhibitor. VIRIP inhibits a wide variety of human immunodeficiency virus type 1 (HIV-1) strains. This modification enhances the antitrypsin ability to inhibit HIV-1infection.
|
| The molecular weight
|
2240.700
|
| Chemical formula
|
C109H158N22O25S2
|
| The purity
|
> 95%
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Reference
|
|
VIR-165
